Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · USD

$22.6

+1.01 (+4.7%)· Recorded snapshot

Market cap	4.4B
Revenue (ttm)	1.3B
Net income (ttm)	-91.5M
EPS (ttm)	-$0.50
Shares out	193.8M
P/E (forward)	49.0x
Volume	2,189,871
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3B
Net income (ttm): -91.5M
EPS (ttm): -$0.50
P/E (forward): 49.0x
Market cap: 4.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E49

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-8.1

P25 n/aP50 n/aP75 n/a

ROIC-9.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LEGN indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001801198
Company name	Legend Biotech Corporation
Country	United States
Country code	US
CUSIP number	52490G102
Earnings date	2026-11-10
Earnings time	bmo
Employees	2,965
Employees change	356
Employees growth	13.65%
Enterprise value	$3.7B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
Industry	Biotechnology
IPO date	2020-06-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US52490G1022
Last 10-K release date	2026-03-10
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$4.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$22.57
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LEGN
U.S. state	New Jersey
Website	https://legendbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2.22%
EV/Sales	2.85x
FCF / EV yield	-3.37%
FCF yield	-2.83%
Forward EV/Sales	2.24x
Forward P/E	49x
Forward P/S	2.67x
P/B ratio	3.4x
P/S ratio	3.38x
Price / tangible book value	3.5x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.15%
EBITDA margin	-3.27%
Gross margin	56.58%
Operating margin	-4.15%
Pretax margin	-4.42%
Profit margin	-7.2%
Profit per employee	$-30,860
Profitable quarters	1
Revenue per employee	$428,803
ROA	-1.92%
ROA (5Y)	-17.34%
ROCE	-3.92%
ROE	-8.08%
ROE (5Y)	-42.95%
ROIC	-9.91%
ROIC (5Y)	-2,147.78%
SBC / revenue	5.25%
Tax / revenue	2.78%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	44.39%
Gross profit growth (Q)	59.2%
Gross profit growth 3Y	146.63%
Gross profit growth 5Y	51.92%
Net income growth quarters	2
Net income growth years	0
Revenue growth	59.55%
Revenue growth (Q)	51.9%
Revenue growth (QoQ)	27.01%
Revenue growth 3Y	97.65%
Revenue growth 5Y	70.25%
Revenue growth quarters	13
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-32.4M
Depreciation and amortization	$11.2M
EBIT	$-52.8M
EBITDA	$-41.6M
EPS	$-0.50
FCF per share	$-0.63
Financing cash flow	$166.5M
Free cash flow	$-121.8M
Free cash flow minus SBC	$-188.5M
Gross profit	$719.3M
Income taxes	$35.3M
Investing cash flow	$330.5M
Net borrowing	$-47.8M
Net cash flow	$406.4M
Net income	$-91.5M
Operating cash flow minus SBC	$-156.1M
Operating income	$-52.8M
Revenue	$1.3B
Stock-based compensation	$66.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.57
Book value per share	$6.35
Debt / equity	0.23
Interest coverage	-2.24
Long-term assets	$523.5M
Long-term liabilities	$117.7M
Net cash (debt)	$686.4M
Net cash / market cap	15.95%
Net cash growth	18.42%
Net debt / equity	-0.56
Piotroski F-Score	2
Property, plant and equipment	$448.2M
Shareholders' equity	$1.2B
Tangible book value	$1.2B
Tangible book value per share	$6.35
Total assets	$1.8B
Total cash	$964.6M
Total debt	$278.2M
Total liabilities	$521.3M
WACC	7.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.74
Current assets	$1.2B
Current liabilities	$403.6M
Current ratio	3.04
Inventory turnover	14.32
Net working capital	$27.4M
Quick ratio	2.88
Working capital	$823.8M
Working capital turnover	1.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.92%
Dividend yield	0%
Shareholder yield	-0.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$23.27
1D price change	4.68%
1M price change	17.37%
1M total return	17.37%
1W price change	17.99%
1W total return	17.99%
1Y price change	-30.17%
1Y return CAGR	-30.19%
1Y total return	-30.17%
20-day SMA	$19.18
200-day SMA	$22.14
3M price change	16.4%
3M total return	16.4%
3Y price change	-64.77%
3Y return CAGR	-29.37%
3Y total return	-64.77%
50-day SMA	$19.55
50-day SMA vs 200-day SMA	50under200
52-week high	$37.50
52-week high date	2026-06-03
52-week low	$16.24
52-week low date	2026-02-04
5Y price change	-56.64%
5Y return CAGR	-15.39%
5Y total return	-56.64%
6M price change	-5.16%
6M total return	-5.16%
All-time high	$77.32
All-time high date	2023-07-21
All-time low	$16.24
All-time low date	2026-02-04
Average true range (ATR)	$1.10
Average volume	2M
Beta (1Y)	1.54
Beta (2Y)	0.66
Beta (5Y)	0.57
Change from 52-week high	-39.81%
Change from 52-week low	38.98%
Change from all-time high	-70.99%
Change from all-time low	38.12%
Change from open	5.96%
Day's gap	-1.21%
Dollar volume	$49.4M
High price	$22.98
Low price	$21.00
Monthly RSI	42.18
Open price	$21.30
Position in 52-week range	79.29%
Premarket change	-1.16%
Premarket close	$21.56
Premarket price	$21.31
Premarket volume	8.8K
Previous close	$21.56
Price vs 150-day SMA	-3.63%
Price vs 20-day SMA	16.92%
Price vs 200-day SMA	1.3%
Price vs 50-day SMA	14.74%
Relative volume	1.12
Return from IPO open	-39.97%
Return from IPO price	-3.43%
RSI	68.68
Sharpe ratio	-0.18
Sharpe ratio (3Y)	-0.41
Sharpe ratio (5Y)	-0.1
Sortino ratio	-0.21
Sortino ratio (3Y)	-0.53
Sortino ratio (5Y)	-0.05
Volume	2.2M
Weekly RSI	51.62
YTD price change	3.17%
YTD total return	3.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	90.8M
Float percentage	46.87%
Shares change (QoQ)	4.7%
Shares change (YoY)	0.92%
Shares held by insiders	0.12%
Shares held by institutions	52.93%
Shares outstanding	193.8M
Short % of shares	19.92%
Short ratio	7.4 days

Deeper analysis on LEGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LEGN report

Is a complete LEGN research report available?

No complete published report is available for Legend Biotech Corporation (LEGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Legend Biotech Corporation (LEGN)

Price

Financial snapshot

Fair-value bridge

Latest news · LEGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LEGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LEGN

Frequently asked questions